TreeWAS – Variant ID: rs278541

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
D17.1 Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk	0.000	0.994	0.006
C44.7 Skin of lower limb, including hip	0.006	0.994	0.000
C44.1 Skin of eyelid, including canthus	0.005	0.995	0.000
R63.4 Abnormal weight loss	0.000	0.995	0.005
C44 Other malignant neoplasms of skin	0.005	0.995	0.000
C44.2 Skin of ear and external auricular canal	0.004	0.996	0.000
D17 Benign lipomatous neoplasm	0.000	0.996	0.004
C44.9 Malignant neoplasm of skin, unspecified	0.004	0.996	0.000
D17.0 Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck	0.000	0.996	0.004
R20.8 Other and unspecified disturbances of skin sensation	0.004	0.996	0.000
G47.3 Sleep apnoea	0.000	0.996	0.004
C44.8 Overlapping lesion of skin	0.004	0.996	0.000
D17.7 Benign lipomatous neoplasm of other sites	0.000	0.996	0.004
D17.9 Benign lipomatous neoplasm, unspecified	0.000	0.996	0.004
D17.2 Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs	0.000	0.996	0.004
Z13.6 Special screening examination for cardiovascular disorders	0.000	0.996	0.003
C44.0 Skin of lip	0.003	0.997	0.000
C44.5 Skin of trunk	0.003	0.997	0.000
D17.6 Benign lipomatous neoplasm of spermatic cord	0.000	0.997	0.003
C43.5 Malignant melanoma of trunk	0.003	0.997	0.000
D17.4 Benign lipomatous neoplasm of intrathoracic organs	0.000	0.997	0.003
C44.4 Skin of scalp and neck	0.003	0.997	0.000
K80.1 Calculus of gallbladder with other cholecystitis	0.000	0.997	0.003
C44.6 Skin of upper limb, including shoulder	0.003	0.997	0.000
I08.1 Disorders of both mitral and tricuspid valves	0.003	0.997	0.000
C44.3 Skin of other and unspecified parts of face	0.003	0.997	0.000
H25.1 Senile nuclear cataract	0.003	0.997	0.000
Z13.9 Special screening examination, unspecified	0.000	0.997	0.003
D17.5 Benign lipomatous neoplasm of intra-abdominal organs	0.000	0.997	0.003
Z01.8 Other specified special examinations	0.000	0.997	0.003
C43-C44 Melanoma and other malignant neoplasms of skin	0.003	0.997	0.000
H25 Senile cataract	0.003	0.997	0.000
Z13 Special screening examination for other diseases and disorders	0.000	0.997	0.003
C43 Malignant melanoma of skin	0.003	0.997	0.000
R20 Disturbances of skin sensation	0.003	0.997	0.000
D17.3 Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites	0.000	0.997	0.002
R20.2 Paraesthesia of skin	0.003	0.997	0.000
Z09.2 Follow-up examination after chemotherapy for other conditions	0.000	0.997	0.003
R63 Symptoms and signs concerning food and fluid intake	0.000	0.997	0.003
H25.8 Other senile cataract	0.002	0.998	0.000
H25.0 Senile incipient cataract	0.002	0.998	0.000
H35.0 Background retinopathy and retinal vascular changes	0.002	0.998	0.000
H35 Other retinal disorders	0.002	0.998	0.000
W19.2 School, other institution and public administrative area	0.000	0.998	0.002
Z13.1 Special screening examination for diabetes mellitus	0.000	0.998	0.002
C43.9 Malignant melanoma of skin, unspecified	0.002	0.998	0.000
Y45.0 Opioids and related analgesics	0.000	0.998	0.002
H25.9 Senile cataract, unspecified	0.002	0.998	0.000
H25.2 Senile cataract, morgagnian type	0.002	0.998	0.000
N50.1 Vascular disorders of male genital organs	0.002	0.998	0.000
W19.4 Street and highway	0.000	0.998	0.002
W19 Unspecified fall	0.000	0.998	0.002
H26.8 Other specified cataract	0.002	0.998	0.000
H35.4 Peripheral retinal degeneration	0.002	0.998	0.000
H36.0 Diabetic retinopathy	0.002	0.998	0.000
Z13.8 Special screening examination for other specified diseases and disorders	0.000	0.998	0.002
Z13.7 Special screening examination for congenital malformations, deformations and chromosomal abnormalities	0.000	0.998	0.002
Z13.4 Special screening examination for certain developmental disorders in childhood	0.000	0.998	0.002
Z13.3 Special screening examination for mental and behavioural disorders	0.000	0.998	0.002
Z13.2 Special screening examination for nutritional disorders	0.000	0.998	0.002
C43.8 Overlapping malignant melanoma of skin	0.002	0.998	0.000
C43.4 Malignant melanoma of scalp and neck	0.002	0.998	0.000
C43.3 Malignant melanoma of other and unspecified parts of face	0.002	0.998	0.000
C43.2 Malignant melanoma of ear and external auricular canal	0.002	0.998	0.000
C43.1 Malignant melanoma of eyelid, including canthus	0.002	0.998	0.000
C43.0 Malignant melanoma of lip	0.002	0.998	0.000
R20.3 Hyperaesthesia	0.002	0.998	0.000
R20.1 Hypoaesthesia of skin	0.002	0.998	0.000
R20.0 Anaesthesia of skin	0.002	0.998	0.000
Z13.0 Special screening examination for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.000	0.998	0.002
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.000	0.998	0.002
H36 Retinal disorders in diseases classified elsewhere	0.002	0.998	0.000
H30-H36 Disorders of choroid and retina	0.002	0.998	0.000
H25-H28 Disorders of lens	0.002	0.998	0.000
R63.6 Insufficient intake of food and water due to self neglect	0.000	0.998	0.002
R63.5 Abnormal weight gain	0.000	0.998	0.002
R63.3 Feeding difficulties and mismanagement	0.000	0.998	0.002
R63.2 Polyphagia	0.000	0.998	0.002
R63.1 Polydipsia	0.000	0.998	0.002
H35.6 Retinal haemorrhage	0.002	0.998	0.000
R63.8 Other symptoms and signs concerning food and fluid intake	0.000	0.998	0.002
R63.0 Anorexia	0.000	0.998	0.002
Z13.5 Special screening examination for eye and ear disorders	0.000	0.998	0.002
D69.6 Thrombocytopenia, unspecified	0.000	0.998	0.002
W19.9 Unspecified place	0.000	0.998	0.002
Y43.3 Other antineoplastic drugs	0.000	0.998	0.002
Y86 Sequelae of other accidents	0.000	0.998	0.002
H35.9 Retinal disorder, unspecified	0.002	0.998	0.000
H35.7 Separation of retinal layers	0.002	0.998	0.000
H35.5 Hereditary retinal dystrophy	0.002	0.998	0.000
H35.2 Other proliferative retinopathy	0.002	0.998	0.000
H35.1 Retinopathy of prematurity	0.002	0.998	0.000
Y43 Primarily systemic agents	0.000	0.998	0.002
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.998	0.002
H26 Other cataract	0.002	0.998	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.000	0.998	0.002
I08 Multiple valve diseases	0.002	0.998	0.000
H35.3 Degeneration of macula and posterior pole	0.002	0.998	0.000
W19.8 Other specified place	0.000	0.998	0.002
W19.5 Trade and service area	0.000	0.998	0.002
W19.0 Home	0.000	0.998	0.002
W19.7 Farm	0.000	0.998	0.002
W19.6 Industrial and construction area	0.000	0.998	0.002
W19.3 Sports and athletics area	0.000	0.998	0.002
W19.1 Residential institution	0.000	0.998	0.002
H34 Retinal vascular occlusions	0.002	0.998	0.000
Z13.83 Encounter for screening for respiratory disorder NEC	0.000	0.998	0.002
Z13.82 Encounter for screening for musculoskeletal disorder	0.000	0.998	0.002
D22.5 Melanocytic naevi of trunk	0.002	0.998	0.000
D22.1 Melanocytic naevi of eyelid, including canthus	0.002	0.998	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.000	0.998	0.002
Y45.8 Other analgesics and antipyretics	0.000	0.998	0.002
Y45.5 4-Aminophenol derivatives	0.000	0.998	0.002
Y45.4 Antirheumatics	0.000	0.998	0.002
Y45.2 Propionic acid derivatives	0.000	0.998	0.002
G47 Sleep disorders	0.000	0.998	0.002
H27 Other disorders of lens	0.002	0.998	0.000
H36.8 Other retinal disorders in diseases classified elsewhere	0.002	0.998	0.000
I08.8 Other multiple valve diseases	0.002	0.998	0.000
H33 Retinal detachments and breaks	0.002	0.998	0.000
Y40 Systemic antibiotics	0.000	0.998	0.002
Y45.1 Salicylates	0.000	0.998	0.002
H28 Cataract and other disorders of lens in diseases classified elsewhere	0.002	0.998	0.000
H32 Chorioretinal disorders in diseases classified elsewhere	0.002	0.998	0.000
H31 Other disorders of choroid	0.002	0.998	0.000
H30 Chorioretinal inflammation	0.002	0.998	0.000
H26.4 After-cataract	0.002	0.998	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.000	0.998	0.002
C43.6 Malignant melanoma of upper limb, including shoulder	0.002	0.998	0.000
H33.2 Serous retinal detachment	0.002	0.998	0.000
H34.2 Other retinal artery occlusions	0.002	0.998	0.000
K51.9 Ulcerative colitis, unspecified	0.000	0.998	0.002
K62.0 Anal polyp	0.002	0.998	0.000
R06.5 Mouth breathing	0.000	0.998	0.002
Y44 Agents primarily affecting blood constituents	0.000	0.998	0.002
D22.7 Melanocytic naevi of lower limb, including hip	0.002	0.998	0.000
H33.0 Retinal detachment with retinal break	0.002	0.998	0.000
H35.8 Other specified retinal disorders	0.002	0.998	0.000
Y40.0 Penicillins	0.000	0.998	0.002
I08.3 Combined disorders of mitral, aortic and tricuspid valves	0.002	0.998	0.000
Z01 Other special examinations and investigations of persons without complaint or reported diagnosis	0.000	0.998	0.002
C43.7 Malignant melanoma of lower limb, including hip	0.002	0.998	0.000
Y85-Y89 Sequelae of external causes of morbidity and mortality	0.000	0.998	0.002
Y43.9 Primarily systemic agent, unspecified	0.000	0.998	0.002
Y43.8 Other primarily systemic agents, not elsewhere classified	0.000	0.998	0.002
Y43.6 Enzymes, not elsewhere classified	0.000	0.998	0.002
Y43.5 Acidifying and alkalising agents	0.000	0.998	0.002
Y43.4 Immunosuppressive agents	0.000	0.998	0.002
Y43.2 Antineoplastic natural products	0.000	0.998	0.002
Y43.1 Antineoplastic antimetabolites	0.000	0.998	0.002
Y43.0 Antiallergic and antiemetic drugs	0.000	0.998	0.002
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.000	0.998	0.002
H26.3 Drug-induced cataract	0.002	0.998	0.000
H26.2 Complicated cataract	0.002	0.998	0.000
H26.1 Traumatic cataract	0.002	0.998	0.000
H26.0 Infantile, juvenile and presenile cataract	0.002	0.998	0.000
Y59 Other and unspecified vaccines and biological substances	0.000	0.998	0.002
Y58 Bacterial vaccines	0.000	0.998	0.002
Y57 Other and unspecified drugs and medicaments	0.000	0.998	0.002
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.000	0.998	0.002
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.998	0.002
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.000	0.998	0.002
Y53 Agents primarily affecting the gastro-intestinal system	0.000	0.998	0.002
Y50 Central nervous system stimulants, not elsewhere classified	0.000	0.998	0.002
Y49 Psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
Y48 Anaesthetics and therapeutic gases	0.000	0.998	0.002
Y47 Sedatives, hypnotics and antianxiety drugs	0.000	0.998	0.002
Y46 Antiepileptics and anti-Parkinsonism drugs	0.000	0.998	0.002
Y41 Other systemic anti-infectives and antiparasitics	0.000	0.998	0.002
I08.9 Multiple valve disease, unspecified	0.002	0.998	0.000
I08.2 Disorders of both aortic and tricuspid valves	0.002	0.998	0.000
Y44.2 Anticoagulants	0.000	0.998	0.002
W19.09 Unspecified fall; Home; During unspecified activity	0.000	0.998	0.001
W19.08 Unspecified fall; Home; While engaged in other specified activities	0.000	0.998	0.001
W19.59 Unspecified fall; Trade and service area; During unspecified activity	0.000	0.998	0.001
W19.81 Unspecified fall; Other specified places; While engaged in leisure activity	0.000	0.998	0.001
D22 Melanocytic naevi	0.002	0.998	0.000
H27.0 Aphakia	0.001	0.998	0.000
H34.9 Retinal vascular occlusion, unspecified	0.001	0.998	0.000
H34.1 Central retinal artery occlusion	0.001	0.998	0.000
H34.0 Transient retinal artery occlusion	0.001	0.998	0.000
O03.9 Complete or unspecified, without complication	0.000	0.998	0.002
D22.0 Melanocytic naevi of lip	0.002	0.998	0.000
D22.6 Melanocytic naevi of upper limb, including shoulder	0.002	0.998	0.000
F32.9 Depressive episode, unspecified	0.000	0.998	0.002
G47.9 Sleep disorder, unspecified	0.000	0.998	0.002
G47.8 Other sleep disorders	0.000	0.998	0.001
G47.4 Narcolepsy and cataplexy	0.000	0.998	0.001
G47.2 Disorders of the sleep-wake schedule	0.000	0.998	0.001
G47.1 Disorders of excessive somnolence [hypersomnias]	0.000	0.998	0.001
H27.9 Disorder of lens, unspecified	0.001	0.998	0.000
H27.8 Other specified disorders of lens	0.001	0.998	0.000
H27.1 Dislocation of lens	0.001	0.998	0.000
T42.4 Benzodiazepines	0.000	0.998	0.002
Y52 Agents primarily affecting the cardiovascular system	0.000	0.998	0.001
Y85 Sequelae of transport accidents	0.000	0.998	0.001
W00-W19 Falls	0.000	0.998	0.002
H28.8 Other disorders of lens in diseases classified elsewhere	0.001	0.998	0.000
H28.2 Cataract in other diseases classified elsewhere	0.001	0.998	0.000
H28.1 Cataract in other endocrine, nutritional and metabolic diseases	0.001	0.998	0.000
H28.0 Diabetic cataract	0.001	0.998	0.000
H30.9 Chorioretinal inflammation, unspecified	0.001	0.998	0.000
H30.8 Other chorioretinal inflammations	0.001	0.998	0.000
H30.2 Posterior cyclitis	0.001	0.998	0.000
H30.1 Disseminated chorioretinal inflammation	0.001	0.998	0.000
H30.0 Focal chorioretinal inflammation	0.001	0.998	0.000
H31.9 Disorder of choroid, unspecified	0.001	0.998	0.000
H31.8 Other specified disorders of choroid	0.001	0.998	0.000
H31.4 Choroidal detachment	0.001	0.998	0.000
H31.3 Choroidal haemorrhage and rupture	0.001	0.998	0.000
H31.2 Hereditary choroidal dystrophy	0.001	0.998	0.000
H31.1 Choroidal degeneration	0.001	0.998	0.000
H31.0 Chorioretinal scars	0.001	0.998	0.000
H32.8 Other chorioretinal disorders in diseases classified elsewhere	0.001	0.998	0.000
H32.0 Chorioretinal inflammation in infectious and parasitic diseases classified elsewhere	0.001	0.998	0.000
H33.5 Other retinal detachments	0.001	0.998	0.000
H33.4 Traction detachment of retina	0.001	0.998	0.000
H33.1 Retinoschisis and retinal cysts	0.001	0.998	0.000
Y40.8 Other systemic antibiotics	0.000	0.998	0.001
Y40.7 Antifungal antibiotics, systemically used	0.000	0.998	0.001
Y40.6 Rifamycins	0.000	0.998	0.001
Y40.5 Aminoglycosides	0.000	0.998	0.001
Y40.4 Tetracyclines	0.000	0.998	0.001
Y40.3 Macrolides	0.000	0.998	0.001
Y40.2 Chloramphenicol group	0.000	0.998	0.001
Y40.1 Cefalosporins and other -lactam antibiotics	0.000	0.998	0.001
M79.62 Pain in limb (Upper arm)	0.002	0.998	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.000	0.998	0.001
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.998	0.001
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.000	0.998	0.001
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.001
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.001
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.000	0.998	0.001
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.998	0.001
Y51.1 Other parasympathomimetics [cholinergics]	0.000	0.998	0.001
Y51.0 Anticholinesterase agents	0.000	0.998	0.001
G47.0 Disorders of initiating and maintaining sleep [insomnias]	0.000	0.998	0.001
Y44.9 Other and unspecified agents affecting blood constituents	0.000	0.998	0.001
Y44.7 Plasma substitutes	0.000	0.998	0.001
Y44.6 Natural blood and blood products	0.000	0.998	0.001
Y44.5 Thrombolytic drugs	0.000	0.998	0.001
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.000	0.998	0.001
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.998	0.001
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.000	0.998	0.001
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.000	0.998	0.001
Y84.2 Radiological procedure and radiotherapy	0.000	0.998	0.002
N85.0 Endometrial glandular hyperplasia	0.000	0.998	0.002
Y40.9 Systemic antibiotic, unspecified	0.000	0.998	0.001
H34.8 Other retinal vascular occlusions	0.001	0.998	0.000
Y85.0 Sequelae of motor-vehicle accident	0.000	0.998	0.001
Z01.9 Special examination, unspecified	0.000	0.998	0.001
Z01.7 Laboratory examination	0.000	0.998	0.001
Z01.6 Radiological examination, not elsewhere classified	0.000	0.998	0.001
Z01.5 Diagnostic skin and sensitisation tests	0.000	0.998	0.001
Z01.3 Examination of blood pressure	0.000	0.998	0.001
Z01.2 Dental examination	0.000	0.998	0.001
Z01.1 Examination of ears and hearing	0.000	0.998	0.001
Z01.0 Examination of eyes and vision	0.000	0.998	0.001
Z09 Follow-up examination after treatment for conditions other than malignant neoplasms	0.000	0.998	0.002
M16.1 Other primary coxarthrosis	0.000	0.998	0.002
N34.2 Other urethritis	0.001	0.998	0.000
Z09.8 Follow-up examination after other treatment for other conditions	0.000	0.998	0.002
Y89 Sequelae of other external causes	0.000	0.998	0.001
Y87 Sequelae of intentional self-harm, assault and events of undetermined intent	0.000	0.998	0.001
J98.1 Pulmonary collapse	0.000	0.999	0.001
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.999	0.001
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.999	0.001
Y41.5 Antiviral drugs	0.000	0.999	0.001
Y41.4 Anthelminthics	0.000	0.999	0.001
Y41.3 Other antiprotozoal drugs	0.000	0.999	0.001
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.999	0.001
Y41.1 Antimycobacterial drugs	0.000	0.999	0.001
Y41.0 Sulphonamides	0.000	0.999	0.001
Y46.8 Antispasticity drugs	0.000	0.999	0.001
Y46.7 Anti-Parkinsonism drugs	0.000	0.999	0.001
Y46.6 Other and unspecified antiepileptics	0.000	0.999	0.001
Y46.5 Valproic acid	0.000	0.999	0.001
Y46.4 Iminostilbenes	0.000	0.999	0.001
Y46.3 Deoxybarbiturates	0.000	0.999	0.001
Y46.2 Hydantoin derivatives	0.000	0.999	0.001
Y46.1 Oxazolidinediones	0.000	0.999	0.001
Y46.0 Succinimides	0.000	0.999	0.001
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.000	0.999	0.001
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.000	0.999	0.001
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.000	0.999	0.001
Y47.4 Bromine compounds	0.000	0.999	0.001
Y47.3 Paraldehyde	0.000	0.999	0.001
Y47.2 Chloral derivatives	0.000	0.999	0.001
Y47.1 Benzodiazepines	0.000	0.999	0.001
Y47.0 Barbiturates, not elsewhere classified	0.000	0.999	0.001
Y48.5 Therapeutic gases	0.000	0.999	0.001
Y48.4 Anaesthetic, unspecified	0.000	0.999	0.001
Y48.3 Local anaesthetics	0.000	0.999	0.001
Y48.2 Other and unspecified general anaesthetics	0.000	0.999	0.001
Y48.1 Parenteral anaesthetics	0.000	0.999	0.001
Y48.0 Inhaled anaesthetics	0.000	0.999	0.001
Y49.9 Psychotropic drug, unspecified	0.000	0.999	0.001
Y49.8 Other psychotropic drugs, not elsewhere classified	0.000	0.999	0.001
Y49.7 Psychostimulants with abuse potential	0.000	0.999	0.001
Y49.6 Psychodysleptics [hallucinogens]	0.000	0.999	0.001
Y49.5 Other antipsychotics and neuroleptics	0.000	0.999	0.001
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.999	0.001
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.999	0.001
Y49.2 Other and unspecified antidepressants	0.000	0.999	0.001
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.999	0.001
Y49.0 Tricyclic and tetracyclic antidepressants	0.000	0.999	0.001
Y50.9 Central nervous system stimulant, unspecified	0.000	0.999	0.001
Y50.8 Other central nervous system stimulants	0.000	0.999	0.001
Y50.2 Methylxanthines, not elsewhere classified	0.000	0.999	0.001
Y50.1 Opioid receptor antagonists	0.000	0.999	0.001
Y50.0 Analeptics	0.000	0.999	0.001
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.999	0.001
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.999	0.001
Y53.7 Emetics	0.000	0.999	0.001
Y53.6 Antidiarrhoeal drugs	0.000	0.999	0.001
Y53.5 Digestants	0.000	0.999	0.001
Y53.4 Other laxatives	0.000	0.999	0.001
Y53.3 Saline and osmotic laxatives	0.000	0.999	0.001
Y53.2 Stimulant laxatives	0.000	0.999	0.001
Y53.1 Other antacids and anti-gastric-secretion drugs	0.000	0.999	0.001
Y53.0 Histamine H2-receptor antagonists	0.000	0.999	0.001
Y54.9 Mineral salts, not elsewhere classified	0.000	0.999	0.001
Y54.8 Agents affecting uric acid metabolism	0.000	0.999	0.001
Y54.7 Agents affecting calcification	0.000	0.999	0.001
Y54.6 Electrolytic, caloric and water-balance agents	0.000	0.999	0.001
Y54.5 Other diuretics	0.000	0.999	0.001
Y54.4 Loop [high-ceiling] diuretics	0.000	0.999	0.001
Y54.3 Benzothiadiazine derivatives	0.000	0.999	0.001
Y54.2 Carbonic-anhydrase inhibitors	0.000	0.999	0.001
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.000	0.999	0.001
Y54.0 Mineralocorticoids	0.000	0.999	0.001
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.999	0.001
Y55.6 Antiasthmatics, not elsewhere classified	0.000	0.999	0.001
Y55.5 Anticommon cold drugs	0.000	0.999	0.001
Y55.4 Expectorants	0.000	0.999	0.001
Y55.3 Antitussives	0.000	0.999	0.001
Y55.2 Other and unspecified agents primarily acting on muscles	0.000	0.999	0.001
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.999	0.001
Y55.0 Oxytocic drugs	0.000	0.999	0.001
Y56.9 Topical agent, unspecified	0.000	0.999	0.001
Y56.8 Other topical agents	0.000	0.999	0.001
Y56.7 Dental drugs, topically applied	0.000	0.999	0.001
Y56.6 Otorhinolaryngological drugs and preparations	0.000	0.999	0.001
Y56.5 Ophthalmological drugs and preparations	0.000	0.999	0.001
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.999	0.001
Y56.3 Emollients, demulcents and protectants	0.000	0.999	0.001
Y56.2 Local astringents and local detergents	0.000	0.999	0.001
Y56.1 Antipruritics	0.000	0.999	0.001
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.999	0.001
Y57.9 Drug or medicament, unspecified	0.000	0.999	0.001
Y57.8 Other drugs and medicaments	0.000	0.999	0.001
Y57.7 Vitamins, not elsewhere classified	0.000	0.999	0.001
Y57.6 Other diagnostic agents	0.000	0.999	0.001
Y57.5 X-ray contrast media	0.000	0.999	0.001
Y57.4 Pharmaceutical excipients	0.000	0.999	0.001
Y57.3 Alcohol deterrents	0.000	0.999	0.001
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.000	0.999	0.001
Y57.1 Lipotropic drugs	0.000	0.999	0.001
Y57.0 Appetite depressants [anorectics]	0.000	0.999	0.001
Y58.9 Other and unspecified bacterial vaccines	0.000	0.999	0.001
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.000	0.999	0.001
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.000	0.999	0.001
Y58.5 Diphtheria vaccine	0.000	0.999	0.001
Y58.4 Tetanus vaccine	0.000	0.999	0.001
Y58.3 Plague vaccine	0.000	0.999	0.001
Y58.2 Cholera vaccine	0.000	0.999	0.001
Y58.1 Typhoid and paratyphoid vaccine	0.000	0.999	0.001
Y58.0 BCG vaccine	0.000	0.999	0.001
Y59.9 Vaccine or biological substance, unspecified	0.000	0.999	0.001
Y59.8 Other specified vaccines and biological substances	0.000	0.999	0.001
Y59.3 Immunoglobulin	0.000	0.999	0.001
Y59.2 Protozoal vaccines	0.000	0.999	0.001
Y59.1 Rickettsial vaccines	0.000	0.999	0.001
Y59.0 Viral vaccines	0.000	0.999	0.001
Y88 Sequelae of surgical and medical care as external cause	0.000	0.999	0.001
D22.9 Melanocytic naevi, unspecified	0.001	0.999	0.000
D22.2 Melanocytic naevi of ear and external auricular canal	0.001	0.999	0.000
N81.1 Cystocele	0.000	0.999	0.001
I08.0 Disorders of both mitral and aortic valves	0.001	0.999	0.000
Y85.9 Sequelae of other and unspecified transport accidents	0.000	0.999	0.001
M19.94 Arthrosis, unspecified (Hand)	0.000	0.999	0.001
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.999	0.001
Y52.8 Antivaricose drugs, including sclerosing agents	0.000	0.999	0.001
Y52.7 Peripheral vasodilators	0.000	0.999	0.001
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.999	0.001
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.999	0.001
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.999	0.001
Y52.1 Calcium-channel blockers	0.000	0.999	0.001
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.999	0.001
R55 Syncope and collapse	0.000	0.999	0.001
W18 Other fall on same level	0.000	0.999	0.001
W17 Other fall from one level to another	0.000	0.999	0.001
W16 Diving or jumping into water causing injury other than drowning or submersion	0.000	0.999	0.001
W15 Fall from cliff	0.000	0.999	0.001
W14 Fall from tree	0.000	0.999	0.001
W12 Fall on and from scaffolding	0.000	0.999	0.001
W11 Fall on and from ladder	0.000	0.999	0.001
W10 Fall on and from stairs and steps	0.000	0.999	0.001
W09 Fall involving playground equipment	0.000	0.999	0.001
W08 Fall involving other furniture	0.000	0.999	0.001
W06 Fall involving bed	0.000	0.999	0.001
W05 Fall involving wheelchair	0.000	0.999	0.001
W04 Fall while being carried or supported by other persons	0.000	0.999	0.001
W03 Other fall on same level due to collision with, or pushing by, another person	0.000	0.999	0.001
W02 Fall involving ice-skates, skis, roller-skates or skateboards	0.000	0.999	0.001
W01 Fall on same level from slipping, tripping and stumbling	0.000	0.999	0.001
W00 Fall on same level involving ice and snow	0.000	0.999	0.001
J35.0 Chronic tonsillitis	0.001	0.999	0.000
Z01.4 Gynaecological examination (general)(routine)	0.000	0.999	0.001
Y52.4 Angiotensin-converting-enzyme inhibitors	0.000	0.999	0.001
Y52.3 Coronary vasodilators, not elsewhere classified	0.000	0.999	0.001
Z09.7 Follow-up examination after combined treatment for other conditions	0.000	0.999	0.001
Z09.4 Follow-up examination after treatment of fracture	0.000	0.999	0.001
Z09.3 Follow-up examination after psychotherapy	0.000	0.999	0.001
Z09.1 Follow-up examination after radiotherapy for other conditions	0.000	0.999	0.001
Y87.2 Sequelae of events of undetermined intent	0.000	0.999	0.001
Y87.1 Sequelae of assault	0.000	0.999	0.001
Y87.0 Sequelae of intentional self-harm	0.000	0.999	0.001
Y89.9 Sequelae of unspecified external cause	0.000	0.999	0.001
Y89.1 Sequelae of war operations	0.000	0.999	0.001
Y89.0 Sequelae of legal intervention	0.000	0.999	0.001
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.999	0.001
F31.0 Bipolar affective disorder, current episode hypomanic	0.001	0.999	0.000
K50.0 Crohn's disease of small intestine	0.000	0.999	0.001
N75.1 Abscess of Bartholin's gland	0.000	0.999	0.001
Y88.2 Sequelae of adverse incidents associated with medical devices in diagnostic and therapeutic use	0.000	0.999	0.001
Y88.1 Sequelae of misadventures to patients during surgical and medical procedures	0.000	0.999	0.001
Y88.0 Sequelae of adverse effects caused by drugs, medicaments and biological substances in therapeutic use	0.000	0.999	0.001
Chapter XX External causes of morbidity and mortality	0.000	0.999	0.001
H47.2 Optic atrophy	0.001	0.999	0.000
R52.1 Chronic intractable pain	0.000	0.999	0.001
H15-H22 Disorders of sclera, cornea, iris and ciliary body	0.001	0.999	0.000
M67.8 Other specified disorders of synovium and tendon	0.000	0.999	0.001
W13 Fall from, out of or through building or structure	0.000	0.999	0.001
Y84 Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure	0.000	0.999	0.001
D22.3 Melanocytic naevi of other and unspecified parts of face	0.001	0.999	0.000
H16.0 Corneal ulcer	0.001	0.999	0.000
N75.0 Cyst of Bartholin's gland	0.000	0.999	0.001
W00.9 Unspecified place	0.000	0.999	0.001
W00.8 Other specified place	0.000	0.999	0.001
W00.4 Street and highway	0.000	0.999	0.001
W00.0 Home	0.000	0.999	0.001
W00.7 Farm	0.000	0.999	0.001
W00.6 Industrial and construction area	0.000	0.999	0.001
W00.5 Trade and service area	0.000	0.999	0.001
W00.3 Sports and athletics area	0.000	0.999	0.001
W00.2 School, other institution and public administrative area	0.000	0.999	0.001
W00.1 Residential institution	0.000	0.999	0.001
W01.9 Unspecified place	0.000	0.999	0.001
W01.8 Other specified place	0.000	0.999	0.001
W01.5 Trade and service area	0.000	0.999	0.001
W01.4 Street and highway	0.000	0.999	0.001
W01.3 Sports and athletics area	0.000	0.999	0.001
W01.2 School, other institution and public administrative area	0.000	0.999	0.001
W01.0 Home	0.000	0.999	0.001
W01.7 Farm	0.000	0.999	0.001
W01.6 Industrial and construction area	0.000	0.999	0.001
W01.1 Residential institution	0.000	0.999	0.001
W02.8 Other specified place	0.000	0.999	0.001
W02.3 Sports and athletics area	0.000	0.999	0.001
W02.9 Unspecified place	0.000	0.999	0.001
W02.7 Farm	0.000	0.999	0.001
W02.6 Industrial and construction area	0.000	0.999	0.001
W02.5 Trade and service area	0.000	0.999	0.001
W02.4 Street and highway	0.000	0.999	0.001
W02.2 School, other institution and public administrative area	0.000	0.999	0.001
W02.1 Residential institution	0.000	0.999	0.001
W02.0 Home	0.000	0.999	0.001
W03.8 Other specified place	0.000	0.999	0.001
W03.3 Sports and athletics area	0.000	0.999	0.001
W03.9 Unspecified place	0.000	0.999	0.001
W03.7 Farm	0.000	0.999	0.001
W03.6 Industrial and construction area	0.000	0.999	0.001
W03.5 Trade and service area	0.000	0.999	0.001
W03.4 Street and highway	0.000	0.999	0.001
W03.2 School, other institution and public administrative area	0.000	0.999	0.001
W03.1 Residential institution	0.000	0.999	0.001
W03.0 Home	0.000	0.999	0.001
W04.9 Unspecified place	0.000	0.999	0.001
W04.8 Other specified place	0.000	0.999	0.001
W04.7 Farm	0.000	0.999	0.001
W04.6 Industrial and construction area	0.000	0.999	0.001
W04.5 Trade and service area	0.000	0.999	0.001
W04.4 Street and highway	0.000	0.999	0.001
W04.3 Sports and athletics area	0.000	0.999	0.001
W04.2 School, other institution and public administrative area	0.000	0.999	0.001
W04.1 Residential institution	0.000	0.999	0.001
W04.0 Home	0.000	0.999	0.001
W05.9 Unspecified place	0.000	0.999	0.001
W05.8 Other specified place	0.000	0.999	0.001
W05.7 Farm	0.000	0.999	0.001
W05.6 Industrial and construction area	0.000	0.999	0.001
W05.5 Trade and service area	0.000	0.999	0.001
W05.4 Street and highway	0.000	0.999	0.001
W05.3 Sports and athletics area	0.000	0.999	0.001
W05.2 School, other institution and public administrative area	0.000	0.999	0.001
W05.1 Residential institution	0.000	0.999	0.001
W05.0 Home	0.000	0.999	0.001
W06.2 School, other institution and public administrative area	0.000	0.999	0.001
W06.9 Unspecified place	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations